Starting Treatment With Agonist Replacement Therapies (START)
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The Food and Drug Administration (FDA) has requested a study comparing buprenorphine/naloxone
(BUP/NX) and methadone (MET) on indices of hepatic safety.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA) University of California, Los Angeles
Collaborators:
National Institute on Drug Abuse (NIDA) University of California, Los Angeles
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Methadone Naloxone